1828
M. A. H. AYED ET AL.
d: 3.45 (s, 3H), 3.69 (s, 3H), 3.80 (s, 3H), 6.96 (d, 2H, J ¼ 8.7 Hz), 7.49 (d, 2H,
J ¼ 8.7 Hz), 8.53 (d, 1H, J ¼ 2.4 Hz), 8.79 (d, 1H, J ¼ 2.4 Hz); 13C NMR (75 MHz,
CDCl3) d: 28.9, 30.1, 55.8, 110.9, 115.2, 128.4, 128.9, 132.4, 135.1, 152.0, 152.4,
154.3, 160.4, 162.0. Anal. calcd for C16H15N3O3: C, 64.64; H, 5.09; N, 14.13%.
Found: C, 64.59; H, 5.06; N, 14.10%. Mass m=z (EI, 30 eV): Mþ297.
1,3-Dimethyl-6-(p-tolyl)-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-2,4-
dione 3c. White solid: mp 148–150 ꢀC; 1H NMR (300 MHz, CDCl3) d: 2.32 (s, 3H),
3.71 (s, 3H), 3.78 (s, 3H), 7.11 (d, 2H, J ¼ 8.6 Hz), 7.56 (d, 2H, J ¼ 8.6 Hz), 8.44 (d,
1H, J ¼ 2.0 Hz), 8.75 (d, 1H, J ¼ 2.0 Hz); 13C NMR (75 MHz, CDCl3) d: 21.1, 27.8,
28.6, 120.5, 128.4, 129.2, 133.7, 135.4, 137.6, 140.9, 148.5, 153.3, 154.0, 164.6. Anal.
calcd. for C16H15N3O2: C, 68.31; H, 5.37; N, 14.94%. Found: C, 68.26; H, 5.35; N,
14.90%. Mass m=z (EI, 30 eV): Mþ281.
1,3-Dimethyl-6-(phenylsulfonyl)-1,2,3,4-tetrahydropyrido[2,3-d]pyrimid-
ine-2,4-dione 3d. White solid: mp 216–218 ꢀC; 1H NMR (300 MHz, CDCl3) d: 3.65
(s, 3H), 3.72 (s, 3H), 7.48 (m, 1H), 7.75 (m, 4H), 8.54 (d, 1H, J ¼ 2.2 Hz), 9.01 (d, 1H,
J ¼ 2.2 Hz); 13C NMR (75 MHz, CDCl3) d: 26.6, 28.3, 127.5, 129.8, 131.3, 132.4,
134.1, 142.7, 145.0, 147.2, 150.9, 154.8, 166.5. Anal. calcd. for C15H13N3O4S: C,
54.37; H, 3.95; N, 12.68%. Found: C, 54.34; H, 3.91; N, 12.62%. Mass m=z (EI,
30 eV): Mþ331.
1,3-Dimethyl-6-(p-tolylsulfonyl)-1,2,3,4-tetrahydropyrido[2,3-d]pyrimid-
ine-2,4-dione 3e. White solid: mp 242–244 ꢀC; 1H NMR (300 MHz, CDCl3) d: 2.38
(s, 3H), 3.49 (s, 3H), 3.68 (s, 3H), 7.43 (d, 2H, J ¼ 8.2 Hz), 7.82 (d, 2H, J ¼ 8.2 Hz),
8.51 (d, 1H, J ¼ 2.3 Hz), 8.97 (d, 1H, J ¼ 2.3 Hz); 13C NMR (75 MHz, CDCl3) d:
20.7, 28.2, 30.5, 126.2, 129.6, 131.1, 133.5, 142.8, 144.0, 145.3, 148.8, 151.7, 155.3,
165.9. Anal. calcd. for C16H15N3O4S: C, 55.64; H, 4.38; N, 12.17%. Found: C,
55.60; H, 4.36; N, 12.13%. Mass m=z (EI, 30 eV): Mþ345.
1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-
carbaldehyde 3f
General procedure. A mixture of 6-amino-1,3-dimethyluracil (1 mmol),
vinamidinum salt 2f (1 mmol), and sodium hydride (2.2 mmol) in DMF (5 mL)
was stirred at 100 ꢀC for 12 h. After cooling to room temperature, H2O (20 mL)
and 1 N HCl (2 mL) were added, and the mixture was allowed to stir at room
temperature for 2 h, then neutralized with saturated aqueous NaHCO3 solution.
The aqueous mixture was extracted with four portions of ethyl acetate. The com-
bined organic extracts were dried over Na2SO4, filtered, and concentrated. The crude
product was purified by column chromatography on silica gel (hexane=EtOAc 8:2) to
give a white solid (mp 168–170 ꢀC).
Spectroscopic data. 1H NMR (300 MHz, CDCl3) d: 3.48 (s, 3H), 3.76 (s, 3H),
8.86 (d, 1H, J ¼ 2.4 Hz), 9.11 (d, 1H, J ¼ 2.4 Hz), 10.09 (s, 1H); 13C NMR (75 MHz,
CDCl3) d: 28.8, 30.2, 110.6, 127.3, 139.2, 151.1, 153.9, 155.5, 160.5, 188.7. Anal. calcd.
for C10H9N3O3: C, 54.79; H, 4.14; N, 19.17%. Found: C, 54.74; H, 4.10; N, 19.15%.
Mass m=z (EI, 30 eV): Mþ219.